Daily Bits April 6th, 2017

Nice. Men in Holland are holding hands in protest against an attack on a gay couple. You may think it’s pointless, but I see solidarity. (Via CNN.)


— x —

An interesting take on the future of journalism? According to Poynter, FT owner Nikkei has invested in micropayments journalism startup Blendle. I’m looking forward to seeing where this goes…

— x —

CoinDesk reported on the unveiling of Samsung’s NexLedger tech. Yet another enterprise blockchain platform…

The innovation is interesting, the structure, also. Apparently Samsung is targeting the consortia set. So is Microsoft. Game on. Since there are so many consortia springing up (and that’s a good thing), the competition is healthy. I need time to dig into the differences between this and the other enterprise offerings, but as far as I’m concerned, the more the merrier. Pushing boundaries, testing methods and competing. The market will then decide.

— x —

23andMe can now sell their genetics testing kit to the general public. It’s hard to fathom the impact this could have on healthcare. If we can all get a heads up on predispositions and risks, then that could inform lifestyle choices and help doctors treat us better.

This does seem like the beginning of nextgen healthcare.

Personally, I’m intrigued, and might give it a try. My daughter wants to know if it will tell her how much of her is Russian (probably very little).

(Via TechCrunch.)

Leave a Reply

Your email address will not be published. Required fields are marked *